CODX vs SYK · rev $3.9M vs P/E 35, rev $25.12B
Co-Diagnostics, Inc. Common Stock (CODX) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SYK revenue for 2025-12-31 was $25.12B. Net income was $3.25B. Revenue was up 290.2% from 2024-12-31 to 2025-12-31. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
CODX currently screens at market cap $31.4M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the CODX and SYK stock pages for the full models.
Not investment advice.